CoStim Pharmaceuticals Overview

  • Year Founded
  • 2012

Year Founded

  • Status
  • Acquired/​Merged

  • Latest Deal Type
  • M&A

  • Latest Deal Amount
  • $82.3M

CoStim Pharmaceuticals General Information

Description

Developer of cancer immunotherapy. The company develops antibody drugs targeting immunological checkpoint control.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Corporate Office
  • 200 Clarendon Street
  • 54th Floor
  • Boston, MA 02116
  • United States
Primary Industry
Drug Delivery
Other Industries
Biotechnology
Pharmaceuticals
Acquirer
Polifin S.R.L.
Vertical(s)
Corporate Office
  • 200 Clarendon Street
  • 54th Floor
  • Boston, MA 02116
  • United States

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

CoStim Pharmaceuticals Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Merger/Acquisition 11-Jan-2024 $82.3M Completed Generating Revenue
4. Merger/Acquisition 17-Feb-2014 Completed Pre-Clinical Trials
3. Early Stage VC 23-Dec-2013 Completed Product Development
2. Early Stage VC (Series A) 29-Mar-2013 $10M $10.7M Completed Product Development
1. Early Stage VC 01-May-2012 $700K $700K Completed Generating Revenue
To view CoStim Pharmaceuticals’s complete valuation and funding history, request access »

CoStim Pharmaceuticals Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series A1
Series A2
To view CoStim Pharmaceuticals’s complete cap table history, request access »

CoStim Pharmaceuticals Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of cancer immunotherapy. The company develops antibody drugs targeting immunological checkpoint control.
Drug Delivery
Boston, MA

Thousand Oaks, CA
 

Boston, MA
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

CoStim Pharmaceuticals Competitors (38)

One of CoStim Pharmaceuticals’s 38 competitors is Amgen, a Formerly PE-Backed company based in Thousand Oaks, CA.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Amgen Formerly PE-Backed Thousand Oaks, CA
Compass Therapeutics Formerly VC-backed Boston, MA
Filana Therapeutics Formerly VC-backed Austin, TX
Regenxbio Formerly VC-backed Rockville, MD
Ionis Pharmaceuticals Corporate Backed or Acquired Carlsbad, CA
You’re viewing 5 of 38 competitors. Get the full list »

CoStim Pharmaceuticals Patents

CoStim Pharmaceuticals Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
EP-3049442-A1 Methods for treating hematologic cancers Inactive 26-Sep-2013
EP-3049442-A4 Methods for treating hematologic cancers Inactive 26-Sep-2013
EP-3757130-A1 Methods for treating hematologic cancers Pending 26-Sep-2013
WO-2015048312-A1 Methods for treating hematologic cancers Inactive 26-Sep-2013 C07K16/2827

CoStim Pharmaceuticals Former Investors (5)

Investor Name Investor Type Holding Investor Since Participating Rounds
Atlas Venture Venture Capital Minority
Curative Ventures Venture Capital Minority
Johnson & Johnson JJDC Corporate Venture Capital Minority
MPM BioImpact Venture Capital Minority
Mass General Brigham Ventures Venture Capital Minority
To view CoStim Pharmaceuticals’s complete investors history, request access »

CoStim Pharmaceuticals FAQs

  • When was CoStim Pharmaceuticals founded?

    CoStim Pharmaceuticals was founded in 2012.

  • Where is CoStim Pharmaceuticals headquartered?

    CoStim Pharmaceuticals is headquartered in Boston, MA.

  • What industry is CoStim Pharmaceuticals in?

    CoStim Pharmaceuticals’s primary industry is Drug Delivery.

  • Is CoStim Pharmaceuticals a private or public company?

    CoStim Pharmaceuticals is a Private company.

  • What is the current valuation of CoStim Pharmaceuticals?

    The current valuation of CoStim Pharmaceuticals is .

  • What is CoStim Pharmaceuticals’s current revenue?

    The current revenue for CoStim Pharmaceuticals is .

  • How much funding has CoStim Pharmaceuticals raised over time?

    CoStim Pharmaceuticals has raised $10.7M.

  • Who are CoStim Pharmaceuticals’s investors?

    Atlas Venture, Curative Ventures, Johnson & Johnson JJDC, MPM BioImpact, and Mass General Brigham Ventures have invested in CoStim Pharmaceuticals.

  • Who are CoStim Pharmaceuticals’s competitors?

    Amgen, Compass Therapeutics, Filana Therapeutics, Regenxbio, and Ionis Pharmaceuticals are some of the 38 competitors of CoStim Pharmaceuticals.

  • When was CoStim Pharmaceuticals acquired?

    CoStim Pharmaceuticals was acquired on 11-Jan-2024.

  • Who acquired CoStim Pharmaceuticals?

    CoStim Pharmaceuticals was acquired by Polifin S.R.L. and Novartis.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process